← Leaderboards
Amy C Rowat
University Of California Los Angeles
$618,362
Attributed
$618,362
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $220.9K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$618,362 · 2
By mechanism
R21$618,362 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Richard Staba$6,894,321
- Earl E Homsher$1,887,200
- Ichiro Nakano$7,010,147
- Daniel H Geschwind$113,418,228
- Franklin B Krasne$1,402,692
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsSamplingMalignant NeoplasmsOverexpressionResearch Project GrantsResponseEffective TherapyGenomicsMediatingNeoplastic CellPublic HealthQuality Of LifeClinical PracticeResistanceBiophysicsClinically RelevantEpithelial To Mesenchymal TransitionCancer CellCellsChemotherapyChemoresistanceNeoplasm MetastasisPhenotypeTreatment Strategy
Grant awards (3)
Identifying novel targets for cancer using high throughput deformability screening$220,894
R21 · FY2025 · CA · contact PI
Re-purposing beta-blockers to improve chemotherapy response$178,678
R21 · FY2022 · CA · contact PI
Re-purposing beta-blockers to improve chemotherapy response$218,790
R21 · FY2021 · CA · contact PI